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Introduction: Uric acid is a metabolite from the breakdown of purines. Elevated serum levels 
(hyperuricaemia)  is known to have an association with cardiovascular risk factors that are often seen in 
obesity, such as hypertension, dyslipidaemia and glucose intolerance. This study will attempt to give an 
insight into this association among individuals with Type 2 Diabetes mellitus.
Methodology: 100 patients with Type 2 diabetes visiting a private health facility in Jos, North Central 
Nigeria participated in this study. The data obtained for analysis from each participant were 
anthropometric indices ( body mass index, waist circumference) and laboratory parameters ( serum lipids 
and uric acid).
Results: 64% of participants were males. 79% of the population were obese and 45% had hyperuricaemia.  
The proportion of females with obesity (94,4%) was significantly greater than that for males (70.3%) but 
there was no significant difference between the proportion of males and females with hyperuricaemia. 
Serum uric acid showed significant positive correlation with waist circumference (p=0.04) and age 
(p=0.03) and had no significant relationship with other variables.
Conclusion: Early detection and treatment of hyperuricaemia in obese patients will help reduce their 
overall risk of cardiovascular events. This is achieved by both non pharmacological and pharmacological 
means.
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INTRODUCTION
Uric acid is a diprotic acid synthesized following 
the catabolism of purines. It was first isolated from 
1
kidney stones by Scheele . The breakdown of 
purines produces xanthine which is metabolized to 
uric acid by xanthine oxidase in mammals. In lower 
animals, the enzyme uricase converts uric acid to 
2allantoin . Uric acid is excreted as a waste product 
in urine and faeces.
However, it does serve certain functions in the 
body such exercising the role of a free radical 
3
scavenger due to its reducing ability . Elevation in 
serum uric acid levels may be due to increased 
production or decreased excretion. Increased 
production of uric acid could be due to ingestion of 
purine rich diet or excessive breakdown of cells 
such as skeletal muscle cells ( rhabdomyolysis ) or 
tumour cells.  Reduced excretion is commonly as a 
result of impairment in renal function. Serum uric 
acid levels above 416 umol/l results in the 
4supersaturation of plasma by uric acid  . The upper 
limit of the reference range for serum uric acid 
.however depends on individual laboratories.    
Obesity is a medical condition in which excess body 
fat has accumulated to the extent that it may have 
adverse effects on the health of the individual, 
leading to reduced life expectancy and/or increased 
5
health problems . The storage of fat in adipose tissue 
serves some physiologic functions such as the 
provision of an energy source and maintenance of 
body temperature. In obesity however, the adverse 
effects of its accumulation outweighs its benefits.  
Obesity is one of the leading causes of preventable 
6
deaths worldwide . In the United States it is 
estimated that about 365000 deaths annually are 
7.
obesity related  As at 2005, about 396 million 
persons worldwide were obese, and that number is 
8
expected to rise to 573 million by the year 2030 . In 
Nigeria, the prevalence of obesity ranges from 
between 8.1% to 22.2% depending on the part of the 
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9country being studied .  Obesity is known to have 
an association with certain cardiovascular risk 
factors, viz: hypertension, diabetes mellitus and 
dyslipidaemia. This association was first described 
by Reaven, and has since been referred to as
10 the Syndrome X  or metabolic syndrome .
           
The Aims of this study are:
1. To  d e t e r m i n e  t h e  p r e v a l e n c e  o f  
hyperuricaemia and obesity among Type 2 
Diabetics
2. To assess the association between 
hyperuricaemia and obesity
3. To determine the correlates of serum uric acid 
among persons with Type 2 Diabetes mellitus
STATISTICAL ANALYSIS
This was done with the Epi Info statistical software 
( version 7.0 ). Chi square was used to test the 
significance of association between categorical 
variables ( hyperuricaemia, obesity ). The Pearson 
correlation coefficient was used to determine the 
relationship between seum uric acid and other 
variables such as age, waist circumference, body 
mass index and serum triglycerides. In all 
instances, p < 0.05 was considered statistically  
significant.
MATERIALS AND METHODS
100 adult Type 2 Diabetics accessing care at a 
private diabetes clinic in Jos, North Central Nigeria 
were enrolled to participate in this study. The 
following anthropometric indices were measured 
in each participant:
Weight: this was measured to the nearest 
kilogramme using a metric weighing scale.
Height: this was measured to the nearest centimeter 
using a stadiometer.
Waist circumference: this was measured at the 
midpoint between the iliac crest and the inferior 
costal margin at expiration using a measuring tape.
The values of weight and height were used to 
calculate the body mass index of each participant in 
2
Kg/m .
Blood samples were collected for triglyceride, 
cholesterol and uric acid assays after an overnight 
fast. Triglyceride and cholesterol  were assayed 
using the glycerol phosphate oxidase  and 
cholesterol oxidase methods respectively. Uric acid 
was assayed using the uricase EMST method.
Definition of terms
1. Hyperuricaemia was defined as serum uric 
4
acid levels greater than 416uMol/l .
2. Obesity was defined as a waist circumference 
19> 94cm in men and > 80cm in women .
RESULTS
Of the 100 participants in the study, 64% were males 
and 36% were females. The mean ages for males 
and females were 55.1+/-7.9 and 55.7+/-10 years 
respectively with no statistically significant 
difference  ( p = 0.77 ). Hyperuricaemia was present 
in 45% of participants while 79% of them were 
obese. 
Figure 1: Distribution of hyperuricaemia among 
participants  ( 0 = present,  1 = absent )
Figure 2: Distribution of obesity among 
participants( 0 = present  1 = absent)
70.3% of males were obese as opposed to 94.4% of 
females. This difference was statistically significant 
2
( X  = 8.08; df=1; p = 0.004). No statistically 
significant difference was observed between the 
39.1% of males with hyperuricaemia compared to 
2
the 55.6% of females with the condition ( X  = 2.53; 
df=1; p = 0.111). obesity showed significant 
2
association with  hyperuriceamia among males ( X  
2= 3.48; df=1; p = 0.04 ) but not among females (X  = 
0.03; df=1; p = 0.87). Serum uric acid showed 
significant correlation with waist circumference ( p 
= 0.04) but not with age ( p=0.07), body mass index 
(p=0.76), serum triglyceride (p=0.22),  or 
cholesterol (p=0.65) ( Table 1 ). However, after 
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adjusting for confounding variables ( waist 
circumference, body mass index, triglyceride, 
cholesterol) age showed significant correlation 
with serum uric acid ( p= 0.03) but the other 
variables did not.  
Figure 3: Scatterplot of uric acid versus age of 
participants
Figure 4: Scatterplot of uric acid versus BMI of 
participants
Figure 4:  Scatterplot of uric acid versus waist 
circumference of participants
Table 1.  The different correlates of uric acid
Correlate  Correlation 
coefficient  



























Assessment of serum uric acid levels in obese 
individuals  i s  impor tant  because  both  
hyperuricaemia and obesity are risk factors for 
cardiovascular events such as cerebrovascular 
disease, myocardial infarction and peripheral 
11vascular disease . In our study population the 
proportion of females who were obese ( 94.4%) was 
greater than that of obese males ( 70.3%) with a 
difference that was statistically significant. These 
results are similar to those of other studies on related 
12,13
topics from other parts of the world . Here in 
14
Nigeria, Adedoyin et al  found out that obesity had 
the highest prevalence among elderly females in a 
population based study. In some other populations 
however, no significant difference between the 
prevalence of obesity among males and females was 
15observed . The comparatively greater physical 
activity level in males may explain the lower 
prevalence rate in them. Also , repeated pregnancies 
in females contributes to a progressive 
16accumulation of adipose tissue .
Hyperuricaemia was more prevalent among the 
females in our study population compared with 
males, although the difference was not statistically 
significant. Some other studies also found no 
significant difference between the prevalence of 
17 
hyperuricaemia in men and women while others 
showed that the condition was more prevalent in 
18,19
men . 
We demonstrated the presence of a significant 
association between hyperuricaemia and obesity 
among the male population but not the females. 
Serum uric acid levels tend to be higher in obese 
individuals compared with normal weight 
20controls . Several studies support this association  
21,22,23between hyperuricaemia and obesity . Others do 
24not . This is probably as a result of the fact that the 
cut-off value used to define hyperuricaemia was not 
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the same in all studies. For instance, Remedios et 
24
al   used 357umol/l as upper limit to define 
hyperuricaemia in their work  while we used 
416umol/l. Age correlated positively with serum 
uric acid in our study. Other workers agree with this 
25,26
finding .  Uric acid however did not correlate 
with serum triglyceride or total cholesterol. 
Research findings on this matter appear to differ for 
reasons still unclear. Some workers demonstrated  
a positive correlation between uric acid and serum 
27,28triglycerides alone . Others showed a correlation 
29with both triglycerides and total cholesterol . Still 
others found no correlation between uric acid and 
24either lipid fraction . 
CONCLUSION
Approach to the management of obesity should be 
holistic. It should involve looking for and 
managing the different associated conditions such 
as hypertension, Diabetes, dyslipidaemia and 
especially hyperuricaemia. Correction of 
hyperuricaemia involves non pharmacological and 
pharmacological measures and will significantly 
reduce the overall risk of cardiovascular events.
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